Ani Pharmaceuticals ANIP Insider Ownership

NASDAQ ANIP

$72.52 -0.15 (-0.21%)

As of: Oct 21, 2026 · 1:16 PM EDT

Insider Holdings by Owner

3.22Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

7.50%

▼-0.087% pp QoQ

Shares Held by Insiders

1.79Mn

filed for Sep 2026

▼-1.15% QoQ

Shares Outstanding

23.85Mn

23,853,000 shares

Direct Holdings

1.19Mn

Indirect: 595.41K

Net Shares Traded (QoQ)

-20.82K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Across the past 12 months, open-market trades by Ani Pharmaceuticals insiders were all sales, totaling $15.08 million (191.88K shares).

A count shows 12 insiders selling ANIP stock on the open market over the past 12 months and none buying.
Nikhil Lalwani (President & CEO) led open-market sales of Ani Pharmaceuticals stock over the past 12 months with $5.05 million (65.8K shares), most recently on September 15, 2026.
The newest open-market trade among Ani Pharmaceuticals insiders came on September 29, 2026, when Stephen P. Carey (SVP & CFO) made a sale of 2.85K shares for $208,050.
Apart from open-market trades, ANIP insiders received 184.96K shares in stock awards, acquired 9.94K shares through option exercises and conversions, gave up 153.98K shares to cover taxes or exercise prices and gave away 3K shares as gifts in the past 12 months.
Per Business Quant, ANIP insiders together hold 1.79Mn shares based on their latest Form 4 filings, or 7.50% of the 23.85Mn shares outstanding; that total is down 1.15% from 1.81Mn shares at the end of Q2 2026 and down 12.35% from 2.04Mn shares at the end of Q3 2025.
Direct holdings account for 1.19Mn shares (66.72%) of ANIP's insider total, and indirect holdings through trusts, partnerships and family members for 595.41K shares (33.28%).
Per Business Quant, 16 insiders of ANIP hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
Ani Pharmaceuticals' top three insider holders by shares held are Muthusamy Shanmugam (Head of R&D, COO Novitium Operations, 537.98K shares), Nikhil Lalwani (President & CEO, 339.09K shares) and Chad Gassert (SVP & Corporate Development & Strategy, 233.41K shares).
The largest insider, Muthusamy Shanmugam, holds 30.07% of ANIP's insider total.
In the past year, 16 insiders of Ani Pharmaceuticals submitted 75 Form 4 filings reporting trades, awards or other transactions.
This summary of Ani Pharmaceuticals insider activity covers Form 4 filings through September 30, 2026.

Form 4 Holdings

Insiders Holding ANIP

Insiders 20

Shares held 3.22Mn

Of outstanding 13.49%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Venture Partners Ii Lp Meridian	TenPercentOwner	1,819,259	1,819,259	56.5%	16 Aug, 2023
2	Nikhil Lalwani	President Ceo	339,089	339,089	10.5%	16 Sep, 2026
3	Stephen P. Carey	Svp Cfo	168,993	168,993	5.3%	30 Sep, 2026
4	James G. Marken	Svp Ops Prod Dev	117,829	117,829	3.7%	11 Jun, 2024
5	Muthusamy Shanmugam	Head Of Rd, Coo Novitium Ops	101,056	101,056	3.1%	02 Mar, 2026
6	Christopher Mutz	Head Of Rare Disease	91,309	91,309	2.8%	13 Mar, 2026
7	Ori Gutwerg	Svp, Generics	75,534	75,534	2.3%	11 Aug, 2026
8	Chad Gassert	Svp Corp. Dev. Strategy	74,916	74,916	2.3%	02 Mar, 2026
9	Meredith Cook	Sr. Vp, General Counsel Sec.	73,424	73,424	2.3%	13 Oct, 2026
10	Krista Davis	Svp, Chief Hr Officer	51,946	51,946	1.6%	10 Mar, 2026
11	Robert E. Jr Brown	Director	49,021	49,021	1.5%	29 Apr, 2022
12	Thomas Haughey	Director	38,878	38,878	1.2%	10 Jun, 2026
13	David Nash	Director	38,561	38,561	1.2%	24 May, 2023
14	Patrick D Walsh	Chairman, Interim Pres. Ceo	38,432	38,432	1.2%	13 May, 2026
15	Thomas Andrew Rowland	Svp, Head Established Brands	38,271	38,271	1.2%	13 May, 2026
16	Renee P Tannenbaum	Director	29,514	29,514	0.9%	10 Jun, 2026
17	Antonio R Pera	Director	27,017	27,017	0.8%	10 Jun, 2026
18	Jeanne Thoma	Director	26,762	26,762	0.8%	14 Sep, 2026
19	Matthew J Leonard	Director	11,221	11,221	0.3%	10 Jun, 2026
20	Henry O Gosebruch	Director	6,662	6,662	0.2%	27 Aug, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,087 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
13 Oct, 2026	Meredith Cook	Sr. Vp, General Counsel Sec.	Disposed S	500	$73.59	$36.80K	73,424	Direct
29 Sep, 2026	Stephen P. Carey	Svp Cfo	Disposed S	2,850	$73.00	$208.05K	168,993	Direct
15 Sep, 2026	Nikhil Lalwani	President Ceo	Disposed S	5,400	$71.00	$383.40K	339,089	Direct
14 Sep, 2026	Meredith Cook	Sr. Vp, General Counsel Sec.	Disposed S	500	$70.79	$35.40K	73,924	Direct
11 Sep, 2026	Jeanne Thoma	Director	Disposed S	1,000	$71.53	$71.53K	26,762	Direct
31 Aug, 2026	Stephen P. Carey	Svp Cfo	Disposed S	2,850	$72.80	$207.48K	171,843	Direct
19 Aug, 2026	Henry O Gosebruch	Director	Acquired A	6,662	$0.00	$0	6,662	Direct
25 Aug, 2026	Nikhil Lalwani	President Ceo	Disposed S	5,400	$74.30	$401.22K	344,489	Direct
13 Aug, 2026	Meredith Cook	Sr. Vp, General Counsel Sec.	Disposed S	500	$75.48	$37.74K	74,424	Direct
10 Aug, 2026	Ori Gutwerg	Svp, Generics	Disposed S	3,162	$77.00	$243.47K	75,534	Direct
29 Jul, 2026	Stephen P. Carey	Svp Cfo	Disposed S	2,850	$81.36	$231.88K	174,693	Direct
18 Jul, 2026	Meredith Cook	Sr. Vp, General Counsel Sec.	Disposed F	2,466	$79.20	$195.31K	74,924	Direct
13 Jul, 2026	Meredith Cook	Sr. Vp, General Counsel Sec.	Disposed S	500	$81.84	$40.92K	77,390	Direct
02 Jul, 2026	Stephen P. Carey	Svp Cfo	Acquired M	3,313	$49.51	$164.03K	180,856	Direct
02 Jul, 2026	Stephen P. Carey	Svp Cfo	Disposed S	3,313	$86.00	$284.92K	177,543	Direct
02 Jul, 2026	Stephen P. Carey	Svp Cfo	Disposed M	3,313	$49.51	$164.03K	3,313	Direct
29 Jun, 2026	Stephen P. Carey	Svp Cfo	Disposed S	2,850	$84.12	$239.74K	177,543	Direct
12 Jun, 2026	Meredith Cook	Sr. Vp, General Counsel Sec.	Disposed S	500	$82.03	$41.02K	77,890	Direct
21 May, 2026	Antonio R Pera	Director	Acquired A	4,357	$0.00	$0	27,017	Direct
21 May, 2026	Thomas Haughey	Director	Acquired A	4,357	$0.00	$0	40,878	Direct

Showing 1 to 20 of 1,087 transactions